Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 24535599
Taira J, Higashimoto Y (2014) Phosphorylation of Grb14 BPS domain by GSK-3 correlates with complex forming of Grb14 and insulin receptor. J Biochem 155, 353-60 24535599
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S358-p - GRB14 (human)
Modsite: MHPYQGRsGCSsQSI SwissProt Entrez-Gene
Orthologous residues
GRB14 (human): S358‑p, GRB14 iso2 (human): S271‑p, GRB14 (mouse): S356‑p, GRB14 iso3 (mouse): , GRB14 (rat): S356‑p
Characterization
Methods used to characterize site in vivo mass spectrometry, microscopy-colocalization with upstream kinase, mutation of modification site
Disease tissue studied:  liver cancer
Relevant cell lines - cell types - tissues:  COS7 (fibroblast)
Cellular systems studied:  cell lines
Species studied:  green monkey, human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE CK2A1 (human)
KINASE GSK3B (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE GSK3B (human) siRNA inhibition of enzyme, modification site within consensus motif, inhibition of upstream enzyme, transfection of wild-type enzyme
Downstream Regulation
Effect of modification (function):  molecular association, regulation, phosphorylation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
INSR (human) BPS Disrupts co-immunoprecipitation
Comments:  Phosphorylation after priming

S362-p - GRB14 (human)
Modsite: QGRsGCSsQSIsPMR SwissProt Entrez-Gene
Orthologous residues
GRB14 (human): S362‑p, GRB14 iso2 (human): S275‑p, GRB14 (mouse): S360‑p, GRB14 iso3 (mouse): , GRB14 (rat): S360‑p
Characterization
Methods used to characterize site in vivo mass spectrometry, microscopy-colocalization with upstream kinase, mutation of modification site
Disease tissue studied:  liver cancer
Relevant cell lines - cell types - tissues:  COS7 (fibroblast)
Cellular systems studied:  cell lines
Species studied:  green monkey, human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE CK2A1 (human)
KINASE GSK3B (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE GSK3B (human) siRNA inhibition of enzyme, modification site within consensus motif, inhibition of upstream enzyme, transfection of wild-type enzyme
Downstream Regulation
Effect of modification (function):  molecular association, regulation, phosphorylation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
INSR (human) BPS Disrupts co-immunoprecipitation
Comments:  Phosphorylation after priming

S366-p - GRB14 (human)
Modsite: GCSsQSIsPMRsIsE SwissProt Entrez-Gene
Orthologous residues
GRB14 (human): S366‑p, GRB14 iso2 (human): S279‑p, GRB14 (mouse): S364‑p, GRB14 iso3 (mouse): , GRB14 (rat): S364‑p
Characterization
Methods used to characterize site in vivo mass spectrometry, microscopy-colocalization with upstream kinase, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  liver cancer
Relevant cell lines - cell types - tissues:  COS7 (fibroblast), HepG2 (hepatic)
Cellular systems studied:  cell lines
Species studied:  green monkey, human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE CK2A1 (human)
KINASE GSK3B (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE GSK3B (human) siRNA inhibition of enzyme, modification site within consensus motif, inhibition of upstream enzyme, transfection of wild-type enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
insulin decrease
GSK-3_inhibitor_IX decrease
Downstream Regulation
Effect of modification (function):  molecular association, regulation, phosphorylation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
INSR (human) BPS Disrupts co-immunoprecipitation
Comments:  Phosphorylation after priming

S370-p - GRB14 (human)
Modsite: QSIsPMRsIsENsLV SwissProt Entrez-Gene
Orthologous residues
GRB14 (human): S370‑p, GRB14 iso2 (human): S283‑p, GRB14 (mouse): S368‑p, GRB14 iso3 (mouse): , GRB14 (rat): S368‑p
Characterization
Enzymes shown to modify site in vitro
Type Enzyme
KINASE CK2A1 (human)
KINASE GSK3B (human)